labetalol has been researched along with amlodipine in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 9 (45.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lund-Johansen, P; Omvik, P | 1 |
Castelino, FV; Collier, D; Wasfy, JH | 1 |
Bendersky, M; Ferdinand, KC; Forcada, P; Grassi, D; Kotliar, C; O'Flaherty, M; Pellizzari, M; Rodriguez, P; Turri, D | 1 |
Chernin, G; Francis, M; Heeringa, SF; Soliman, NA | 1 |
Kauntia, R; Pandit, VR; Prabhu, MM; Seshadri, S; Valsalan, R | 1 |
Campbell, P; Jain, K; Schuchard, G; Singh, KP; White, WB | 1 |
Abrams, RI; Baxi, PV; Herring, MJ; Korbet, SM; Lichtenstein, SJ | 1 |
Lodebo, BT; Pearlman, B | 1 |
Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
1 review(s) available for labetalol and amlodipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for labetalol and amlodipine
Article | Year |
---|---|
Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Emergencies; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hypertension; Labetalol; Male; Middle Aged; Perindopril; Rest; Retrospective Studies; Treatment Outcome | 2008 |
18 other study(ies) available for labetalol and amlodipine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines | 1993 |
A 36-year-old man with paresthesias and a headache.
Topics: Adult; Amlodipine; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Guanine; Headache; Hepatitis B; Humans; Labetalol; Lymphoma, Non-Hodgkin; Male; Paresthesia; Prednisone; Substance Abuse, Intravenous; Sural Nerve; Treatment Outcome; Vasculitis | 2008 |
Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade?
Topics: Albumins; Amlodipine; Angiotensins; Antihypertensive Agents; Captopril; Drug Resistance; Drug Therapy, Combination; Furosemide; Glomerulosclerosis, Focal Segmental; Humans; Infant; Labetalol; Male; Nephrotic Syndrome; Prednisolone; Remission Induction; Renin-Angiotensin System | 2009 |
Late postpartum preeclampsia with posterior reversible encephalopathy syndrome.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Blindness, Cortical; Eclampsia; Female; Humans; Labetalol; Posterior Leukoencephalopathy Syndrome; Postpartum Period; Pregnancy; Time Factors | 2009 |
Severe circadian hypertension in a young man.
Topics: Amlodipine; Angioplasty, Balloon; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Humans; Hypertension; Labetalol; Male; Radiography; Renal Artery; Renal Artery Obstruction; Young Adult | 2011 |
Without Warning: Scleroderma Renal Crisis.
Topics: Acute Kidney Injury; Amlodipine; Antihypertensive Agents; Humans; Hypertension; Labetalol; Lisinopril; Male; Nicardipine; Scleroderma, Limited | 2019 |
Renin secreting tumour: a rare cause of secondary hypertension.
Topics: Adult; Amlodipine; Antihypertensive Agents; Female; Humans; Hypertension; Kidney Neoplasms; Labetalol; Nephrectomy; Renin; Seizures; Tomography, X-Ray Computed; Young Adult | 2021 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |